Across TCGA pan-cancer cohorts, RNU6-209P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-209P data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNU6-209P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-209P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LAML are the cancer types where RNU6-209P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	1.000	0.358	.031	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU6-209P tumor-vs-normal RNA expression · all RNU6-209P data types